Primary aneurysmal bone cysts.

Abstract

AIMS:

The aim of this study was to analyze the complications and outcomes of treatment in a series of previously untreated patients with a primary aneurysmal bone cyst (ABC) who had been treated by percutaneous sclerosant therapy using polidocanol.

METHODS:

Between January 2010 and December 2016, 56 patients were treated primarily with serial intralesional sclerosant injections. Their mean age was 20 years (1 to 54). The sites involved were clavicle (n = 3), humeri (n = 11), radius (n = 1), ulna (n = 3), hand (n = 2), pelvis (n = 12), femur (n = 7), tibia (n = 13), fibula (n = 3), and foot (n = 1). After histopathological confirmation of the diagnosis, 3% polidocanol (hydroxypolyaethoxydodecan) was injected into the lesion under image intensifier guidance. Patients were evaluated clinically and radiologically every six to eight weeks. In the absence of clinical and/or radiological response, a repeat sclerosant injection was given after eight to 12 weeks and repeated at similar intervals if necessary.

RESULTS:

There were no complications of treatment. One patient was lost to follow-up. Overall, 46/55 (84%) of lesions healed after one or more injections of polidocanol: 24/55 (44%) patients healed with a single injection, and 43/55 (78%) within two injections. Of these 46, four (9%) patients developed local recurrence, two of whom healed with a repeat sclerosant injection. Thus, 44/55 (80%) patients of primary ABC healed with sclerotherapy. The mean follow-up was 62 months (20 to 111). The local recurrence free survival (LRFS) with percutaneous sclerosant therapy with polidocanol was 100%, 98% (95% confidence interval (CI) 85 to 100) and 93% (95% CI 78 to 98) at two, three, and five years, respectively.

CONCLUSION:

Percutaneous sclerotherapy using polidocanol is a safe, effective, minimally invasive and inexpensive method of treating a primary ABC of the limbs or pelvis. Cite this article: Bone Joint J 2020;102-B(2):186-190.

• Authors: Ajay Puri, Prateek Hegde, Ashish Gulia, Mishil Parikh
• Journal: The bone & joint journal (Bone Joint J) Vol. 102-B Issue 2 Pg. 186-190 (Feb 2020) ISSN: 2049-4408 [Electronic] England
• PMID: 32009434 (Publication Type: Journal Article)

Chemical References

• Sclerosing Solutions
• Polidocanol

Topics

• Adolescent
• Adult
• Bone Cysts, Aneurysmal (therapy)
• Child
• Child, Preschool
• Female
• Humans
• Infant
• Injections, Intralesional
• Male
• Middle Aged
• Polidocanol (administration & dosage)
• Sclerosing Solutions (administration & dosage)
• Sclerotherapy
• Treatment Outcome
• Young Adult